PROTEIN DELIVERY INC has a total of 16 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are KOREA PRIME PHARM CO LTD, SYNAIRGEN RES LTD and BIRDIE BIOPHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Ekwuribe Nnochiri Nkem | 8 |
#2 | Ekwuribe Nnochiri N | 2 |
#3 | Ramaswamy Muthukumar | 2 |
#4 | Radhakrishnan Balasingam | 1 |
#5 | Ekwuribe Nnochiri Nken | 1 |
#6 | Rajagopalan Jayanthi | 1 |
#7 | Akwurib N N | 1 |
#8 | Allaudeen Hameedsulthan S | 1 |
#9 | Ekwuribe Nnochiri | 1 |
#10 | Ekwuribe Nnichiri Nkem | 1 |
Publication | Filing date | Title |
---|---|---|
US6191105B1 | Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin | |
US5681811A | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same | |
CN1120457A | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same | |
US5359030A | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |